Pregabalin (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pregabalin" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

80nih.gov

4^th place

13^th place

74web.archive.org

1^st place

66doi.org

2^nd place

4^th place

27semanticscholar.org

11^th place

330^th place

11books.google.com

3^rd place

6^th place

9drugs.com

399^th place

480^th place

6archive.org

6^th place

2^nd place

6fda.gov

447^th place

792^nd place

5gov.uk

432^nd place

1,425^th place

5scholar.google.com

1,697^th place

1,182^nd place

2handle.net

102^nd place

411^th place

2nihr.ac.uk

low place

2usdoj.gov

2,755^th place

5,814^th place

1europa.eu

68^th place

182^nd place

1who.int

195^th place

203^rd place

1recovered.org

low place

1release.org.uk

low place

1cpdonline.co.uk

low place

1science.org

1,160^th place

5,389^th place

1northbynorthwestern.com

low place

1jbc.org

4,455^th place

2,929^th place

1pap.pl

4,592^nd place

low place

1seekingalpha.com

5,344^th place

5,989^th place

1reuters.com

49^th place

96^th place

1au.dk

8,222^nd place

low place

1ox.ac.uk

613^th place

703^rd place

1ucl.ac.uk

1,306^th place

1,231^st place

1wfsbp.org

low place

1canberratimes.com.au

4,198^th place

7,349^th place

1federalregister.gov

2,474^th place

low place

1pfizer.com.au

low place

1medicines.org.uk

3,823^rd place

9,839^th place

1psu.edu

207^th place

525^th place

1localhealthrx.com

low place

1harvard.edu

18^th place

44^th place

1felleskatalogen.no

low place

1tidsskriftet.no

low place

1publishing.service.gov.uk

1,877^th place

4,254^th place

1bmj.com

1,226^th place

1,806^th place

1stopmedicarefraud.gov

low place

1drugstorenews.com

low place

1prnewswire.com

406^th place

1,043^rd place

146brooklyn.com

low place

1fiercepharma.com

low place

1nytimes.com

7^th place

35^th place

1bbc.co.uk

8^th place

18^th place

1sec.gov

572^nd place

529^th place

1acs.org

1,248^th place

1,167^th place

1espacenet.com

800^th place

2,428^th place

1bloomberg.com

99^th place

159^th place

1finnegan.com

low place

1pulsetoday.co.uk

low place

46brooklyn.com

"Generic Lyrica launches at 97% discount to brand version". 46brooklyn Research. July 23, 2019. Diarsipkan dari versi aslinya tanggal July 16, 2020. Diakses tanggal December 25, 2019.

acs.org

cen.acs.org

Jacoby M (2008). "Financial Windfall from Lyrica". Chemical & Engineering News. 86 (10): 56–61. doi:10.1021/cen-v086n010.p056. Diarsipkan dari versi aslinya tanggal October 26, 2020. Diakses tanggal October 26, 2020.

archive.org

Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, Busch JA, Randinitis EJ, Corrigan BW, Haig GM, Boyd RA, Wesche DL (August 2010). "Clinical pharmacokinetics of pregabalin in healthy volunteers". Journal of Clinical Pharmacology. 50 (8): 941–950. doi:10.1177/0091270009352087. PMID 20147618. S2CID 9905501.
Finnerup NB, Sindrup SH, Jensen TS (September 2010). "The evidence for pharmacological treatment of neuropathic pain". Pain. 150 (3): 573–581. doi:10.1016/j.pain.2010.06.019. PMID 20705215. S2CID 29830155.
Wensel TM, Powe KW, Cates ME (March 2012). "Pregabalin for the treatment of generalized anxiety disorder". The Annals of Pharmacotherapy. 46 (3): 424–429. doi:10.1345/aph.1Q405. PMID 22395254. S2CID 26320851.
Baselt RC (2008). Disposition of Toxic Drugs and Chemicals in Man (Edisi 8th). Biomedical Publications. hlm. 1296–1297. ISBN 978-0-9626523-7-0.
Bryans JS, Wustrow DJ (March 1999). "3-substituted GABA analogs with central nervous system activity: a review". Medicinal Research Reviews. 19 (2): 149–177. doi:10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B. PMID 10189176. S2CID 38496241.
McElroy SL, Keck PE, Post RM, ed. (2008). Antiepileptic Drugs to Treat Psychiatric Disorders. INFRMA-HC. hlm. 370. ISBN 978-0-8493-8259-8.

au.dk

pure.au.dk

Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, Rey RD, Schug SA, Jensen TS, Tölle TR, Ushida T, Whalen E (January 2021). "Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration" (PDF). Postgraduate Medicine. 133 (1). Informa UK Limited: 1–9. doi:10.1080/00325481.2020.1857992. PMID 33423590. S2CID 231574963. Diarsipkan (PDF) dari versi aslinya tanggal February 27, 2024. Diakses tanggal February 19, 2024.

bbc.co.uk

news.bbc.co.uk

"Pfizer agrees record fraud fine". BBC News. September 2, 2009. Diarsipkan dari versi aslinya tanggal September 8, 2009. Diakses tanggal December 21, 2017.

bloomberg.com

Decker S (February 6, 2014). "Pfizer Wins Ruling to Block Generic Lyrica Until 2018". Bloomberg. Diarsipkan dari versi aslinya tanggal February 8, 2014. Diakses tanggal October 26, 2020.

bmj.com

Mayor S (October 2018). "Pregabalin and gabapentin become controlled drugs to cut deaths from misuse". BMJ. 363: k4364. doi:10.1136/bmj.k4364. PMID 30327316. S2CID 53520780. Diarsipkan dari versi aslinya tanggal August 9, 2019. Diakses tanggal February 6, 2019.

books.google.com

Wyllie E, Cascino GD, Gidal BE, Goodkin HP (February 17, 2012). Wyllie's Treatment of Epilepsy: Principles and Practice. Lippincott Williams & Wilkins. hlm. 423. ISBN 978-1-4511-5348-4.
Kirsch D (October 10, 2013). Sleep Medicine in Neurology. John Wiley & Sons. hlm. 241. ISBN 978-1-118-76417-6.
Frye M, Moore K (2009). "Gabapentin and Pregabalin". Dalam Schatzberg AF, Nemeroff CB (ed.). The American Psychiatric Publishing Textbook of Psychopharmacology. hlm. 767–77. doi:10.1176/appi.books.9781585623860.as38. ISBN 978-1-58562-309-9. Diarsipkan dari versi aslinya tanggal February 27, 2024. Diakses tanggal September 1, 2022.
Elaine Wyllie; Gregory D. Cascino; Barry E. Gidal; Howard P. Goodkin (February 17, 2012). Wyllie's Treatment of Epilepsy: Principles and Practice. Lippincott Williams & Wilkins. hlm. 423. ISBN 978-1-4511-5348-4.
Honorio Benzon; James P. Rathmell; Christopher L. Wu; Dennis C. Turk; Charles E. Argoff; Robert W Hurley (September 11, 2013). Practical Management of Pain. Elsevier Health Sciences. hlm. 1006. ISBN 978-0-323-17080-2.
Kaye AD, Vadivelu N, Urman RD (2014). Substance Abuse: Inpatient and Outpatient Management for Every Clinician. Springer. hlm. 324. ISBN 9781493919512. Diarsipkan dari versi aslinya tanggal March 1, 2022. Diakses tanggal August 24, 2020.
Lin GQ, You QD, Cheng JF, ed. (August 8, 2011). Chiral Drugs: Chemistry and Biological Action. John Wiley & Sons. hlm. 88. ISBN 9781118075630. Diarsipkan dari versi aslinya tanggal April 25, 2022. Diakses tanggal August 17, 2016 – via Google Books.
McMahon SB (2013). Wall and Melzack's textbook of pain (Edisi 6th). Philadelphia, PA: Elsevier/Saunders. hlm. 515. ISBN 9780702040597.
Wheless JW, Willmore J, Brumback RA (2009). Advanced Therapy in Epilepsy. PMPH-USA. hlm. 302. ISBN 978-1-60795-004-2.
Vardanyan R, Hruby V (January 7, 2016). Synthesis of Best-Seller Drugs. Elsevier Science. hlm. 158. ISBN 978-0-12-411524-8. Diarsipkan dari versi aslinya tanggal August 29, 2021. Diakses tanggal June 22, 2018.
Andrushko V, Andrushko N (August 16, 2013). Stereoselective Synthesis of Drugs and Natural Products. John Wiley & Sons. hlm. 869. ISBN 978-1-118-62833-1. Diarsipkan dari versi aslinya tanggal August 29, 2021. Diakses tanggal June 22, 2018.

canberratimes.com.au

Mannix L (December 18, 2018). "This popular drug is linked to addiction and suicide. Why do doctors keep prescribing it?". The Canberra Times. Diarsipkan dari asli tanggal December 18, 2018. Diakses tanggal December 18, 2018.

cpdonline.co.uk

"What are Class C Drugs?". October 31, 2022. Diarsipkan dari versi aslinya tanggal May 6, 2024. Diakses tanggal May 6, 2024.

doi.org

Schifano F (June 2014). "Misuse and abuse of pregabalin and gabapentin: cause for concern?". CNS Drugs. 28 (6): 491–496. doi:10.1007/s40263-014-0164-4. PMID 24760436.
Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, Busch JA, Randinitis EJ, Corrigan BW, Haig GM, Boyd RA, Wesche DL (August 2010). "Clinical pharmacokinetics of pregabalin in healthy volunteers". Journal of Clinical Pharmacology. 50 (8): 941–950. doi:10.1177/0091270009352087. PMID 20147618. S2CID 9905501.
Frampton JE (September 2014). "Pregabalin: a review of its use in adults with generalized anxiety disorder". CNS Drugs. 28 (9): 835–854. doi:10.1007/s40263-014-0192-0. PMID 25149863. S2CID 5349255.
Iftikhar IH, Alghothani L, Trotti LM (December 2017). "Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis". European Journal of Neurology. 24 (12): 1446–1456. doi:10.1111/ene.13449. PMID 28888061. S2CID 22262972.
Frye M, Moore K (2009). "Gabapentin and Pregabalin". Dalam Schatzberg AF, Nemeroff CB (ed.). The American Psychiatric Publishing Textbook of Psychopharmacology. hlm. 767–77. doi:10.1176/appi.books.9781585623860.as38. ISBN 978-1-58562-309-9. Diarsipkan dari versi aslinya tanggal February 27, 2024. Diakses tanggal September 1, 2022.
Calandre EP, Rico-Villademoros F, Slim M (2016). "Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". Expert Rev Neurother. 16 (11): 1263–1277. doi:10.1080/14737175.2016.1202764. PMID 27345098. S2CID 33200190.
Dooley DJ, Taylor CP, Donevan S, Feltner D (2007). "Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission". Trends Pharmacol. Sci. 28 (2): 75–82. doi:10.1016/j.tips.2006.12.006. PMID 17222465.
Calandre EP, Rico-Villademoros F, Slim M (November 2016). "Alpha₂delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". Expert Review of Neurotherapeutics. 16 (11): 1263–1277. doi:10.1080/14737175.2016.1202764. PMID 27345098. S2CID 33200190.
Uchitel OD, Di Guilmi MN, Urbano FJ, Gonzalez-Inchauspe C (2010). "Acute modulation of calcium currents and synaptic transmission by gabapentinoids". Channels. 4 (6): 490–496. doi:10.4161/chan.4.6.12864. hdl:11336/20897. PMID 21150315.
Mishriky BM, Waldron NH, Habib AS (January 2015). "Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis". British Journal of Anaesthesia. 114 (1): 10–31. doi:10.1093/bja/aeu293. PMID 25209095.
Andruszkiewicz R, Silverman RB (December 1990). "4-Amino-3-alkylbutanoic acids as substrates for gamma-aminobutyric acid aminotransferase". The Journal of Biological Chemistry. 265 (36): 22288–22291. doi:10.1016/S0021-9258(18)45702-X. PMID 2266125. Diarsipkan dari versi aslinya tanggal August 27, 2022. Diakses tanggal August 25, 2016.
Dworkin RH, Kirkpatrick P (June 2005). "Pregabalin". Nature Reviews. Drug Discovery. 4 (6): 455–456. doi:10.1038/nrd1756. PMID 15959952. S2CID 265702200. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
Panebianco M, Bresnahan R, Marson AG (March 2022). "Pregabalin add-on for drug-resistant focal epilepsy". The Cochrane Database of Systematic Reviews. 3 (3): CD005612. doi:10.1002/14651858.CD005612.pub5. PMC 8962962. PMID 35349176.
Zhou Q, Zheng J, Yu L, Jia X (October 2012). "Pregabalin monotherapy for epilepsy". The Cochrane Database of Systematic Reviews. 10: CD009429. doi:10.1002/14651858.CD009429.pub2. PMID 23076957.
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T (September 2010). "EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision". European Journal of Neurology. 17 (9): 1113–1e88. doi:10.1111/j.1468-1331.2010.02999.x. PMID 20402746. S2CID 14236933.
Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA (January 2019). "Pregabalin for neuropathic pain in adults". The Cochrane Database of Systematic Reviews. 1 (1): CD007076. doi:10.1002/14651858.CD007076.pub3. PMC 6353204. PMID 30673120.
Finnerup NB, Sindrup SH, Jensen TS (September 2010). "The evidence for pharmacological treatment of neuropathic pain". Pain. 150 (3): 573–581. doi:10.1016/j.pain.2010.06.019. PMID 20705215. S2CID 29830155.
"Combination therapy for painful diabetic neuropathy is safe and effective". NIHR Evidence (dalam bahasa Inggris). April 6, 2023. doi:10.3310/nihrevidence_57470. S2CID 258013544. Diarsipkan dari versi aslinya tanggal April 28, 2023. Diakses tanggal April 28, 2023.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice AS, Bouhassira D, Bennett DL, Selvarajah D (August 2022). "Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial". Lancet. 400 (10353): 680–690. doi:10.1016/s0140-6736(22)01472-6. PMC 9418415. PMID 36007534.
Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, Rey RD, Schug SA, Jensen TS, Tölle TR, Ushida T, Whalen E (January 2021). "Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration" (PDF). Postgraduate Medicine. 133 (1). Informa UK Limited: 1–9. doi:10.1080/00325481.2020.1857992. PMID 33423590. S2CID 231574963. Diarsipkan (PDF) dari versi aslinya tanggal February 27, 2024. Diakses tanggal February 19, 2024.
Bennett MI, Laird B, van Litsenburg C, Nimour M (November 2013). "Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature". Pain Medicine. 14 (11): 1681–1688. doi:10.1111/pme.12212. PMID 23915361.
Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J (August 2012). "The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis". Anesthesia and Analgesia. 115 (2): 428–442. doi:10.1213/ANE.0b013e318249d36e. hdl:10315/27968. PMID 22415535. S2CID 18933131.
Chaparro LE, Smith SA, Moore RA, Wiffen PJ, Gilron I (July 2013). "Pharmacotherapy for the prevention of chronic pain after surgery in adults". The Cochrane Database of Systematic Reviews. 2021 (7): CD008307. doi:10.1002/14651858.CD008307.pub2. PMC 6481826. PMID 23881791.
Hamilton TW, Strickland LH, Pandit HG (August 2016). "A Meta-Analysis on the Use of Gabapentinoids for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty". The Journal of Bone and Joint Surgery. American Volume. 98 (16): 1340–1350. doi:10.2106/jbjs.15.01202. PMID 27535436. Diarsipkan dari versi aslinya tanggal September 29, 2020. Diakses tanggal August 24, 2020.
Patel R, Dickenson AH (April 2016). "Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain". Pharmacology Research & Perspectives. 4 (2): e00205. doi:10.1002/prp2.205. PMC 4804325. PMID 27069626.
Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N (February 2019). "Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis" (PDF). Lancet. 393 (10173): 768–777. doi:10.1016/S0140-6736(18)31793-8. PMID 30712879. S2CID 72332967. Diarsipkan (PDF) dari versi aslinya tanggal March 13, 2020. Diakses tanggal September 8, 2020.; "Supplemental Appendices" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal March 9, 2020.; "Authors' Reply" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal October 17, 2020.
"Review finds little evidence to support gabapentinoid use in bipolar disorder or insomnia". NIHR Evidence (Plain English summary) (dalam bahasa Inggris). National Institute for Health and Care Research. October 17, 2022. doi:10.3310/nihrevidence_54173. S2CID 252983016. Diarsipkan dari versi aslinya tanggal November 27, 2022. Diakses tanggal October 27, 2022.
Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A (March 2022). "Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale". Molecular Psychiatry. 27 (3): 1339–1349. doi:10.1038/s41380-021-01386-6. PMC 9095464. PMID 34819636.
Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A (March 2022). "Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale". Molecular Psychiatry. 27 (3): 1339–1349. doi:10.1038/s41380-021-01386-6. PMC 9095464. PMID 34819636.
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ (June 2012). "Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care" (PDF). International Journal of Psychiatry in Clinical Practice. 16 (2): 77–84. doi:10.3109/13651501.2012.667114. PMID 22540422. S2CID 16253034. Diarsipkan (PDF) dari versi aslinya tanggal April 3, 2018. Diakses tanggal October 16, 2020.
Wensel TM, Powe KW, Cates ME (March 2012). "Pregabalin for the treatment of generalized anxiety disorder". The Annals of Pharmacotherapy. 46 (3): 424–429. doi:10.1345/aph.1Q405. PMID 22395254. S2CID 26320851.
Owen RT (September 2007). "Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety". Drugs of Today. 43 (9): 601–610. doi:10.1358/dot.2007.43.9.1133188. PMID 17940637.
Bandelow B, Wedekind D, Leon T (July 2007). "Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention". Expert Review of Neurotherapeutics. 7 (7): 769–781. doi:10.1586/14737175.7.7.769. PMID 17610384. S2CID 6229344.
Ng QX, Han MX, Teoh SE, Yaow CY, Lim YL, Chee KT (August 2021). "A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder". Pharmaceuticals. 14 (9): 834. doi:10.3390/ph14090834. PMC 8469561. PMID 34577534.
Giménez-Campos MS, Pimenta-Fermisson-Ramos P, Díaz-Cambronero JI, Carbonell-Sanchís R, López-Briz E, Ruíz-García V (January 2022). "A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain". Atencion Primaria. 54 (1). Elsevier BV: 102144. doi:10.1016/j.aprim.2021.102144. PMC 8515246. PMID 34637958.
Shanthanna H, Gilron I, Rajarathinam M, AlAmri R, Kamath S, Thabane L, Devereaux PJ, Bhandari M (August 2017). "Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials". PLOS Medicine. 14 (8): e1002369. doi:10.1371/journal.pmed.1002369. PMC 5557428. PMID 28809936.
Freynhagen R, Backonja M, Schug S, Lyndon G, Parsons B, Watt S, Behar R (December 2016). "Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review". CNS Drugs. 30 (12): 1191–1200. doi:10.1007/s40263-016-0390-z. PMC 5124051. PMID 27848217.
Linde M, Mulleners WM, Chronicle EP, McCrory DC (June 2013). "Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults". The Cochrane Database of Systematic Reviews. 6 (6): CD010609. doi:10.1002/14651858.CD010609. PMC 6599858. PMID 23797675.
Onakpoya IJ, Thomas ET, Lee JJ, Goldacre B, Heneghan CJ (January 2019). "Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials". BMJ Open. 9 (1): e023600. doi:10.1136/bmjopen-2018-023600. PMC 6347863. PMID 30670513.
Slocum GW, Schult RF, Gorodetsky RM, Wiegand TJ, Kamali M, Acquisto NM (January 1, 2018). "Pregabalin and paradoxical reaction of seizures in a large overdose". Toxicology Communications. 2 (1): 19–20. doi:10.1080/24734306.2018.1458465. S2CID 79760296.
Millar J, Sadasivan S, Weatherup N, Lutton S (September 7, 2013). "Lyrica Nights–Recreational Pregabalin Abuse in an Urban Emergency Department". Emergency Medicine Journal. 30 (10): 874.2–874. doi:10.1136/emermed-2013-203113.20. S2CID 73986091.
Tanyıldız B, Kandemir B, Mangan MS, Tangılntız A, Göktaş E, Şimşek S (October 2018). "Bilateral Serous Macular Detachment After Attempted Suicide with Pregabalin". Turkish Journal of Ophthalmology. 48 (5): 254–257. doi:10.4274/tjo.70923. PMC 6216534. PMID 30405948.
Desai A, Kherallah Y, Szabo C, Marawar R (March 2019). "Gabapentin or pregabalin induced myoclonus: A case series and literature review". Journal of Clinical Neuroscience. 61: 225–234. doi:10.1016/j.jocn.2018.09.019. PMID 30381161. S2CID 53165515.
Murphy NG, Mosher L (2008). "79. Severe myoclonus from pregabalin (Lyrica) due to chronic renal insufficiency". Clinical Toxicology. 46 (7): 604. doi:10.1080/15563650802255033. S2CID 218857181.
Yoo L, Matalon D, Hoffman RS, Goldfarb DS (December 2009). "Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure" (PDF). American Journal of Kidney Diseases. 54 (6): 1127–1130. CiteSeerX 10.1.1.955.4223. doi:10.1053/j.ajkd.2009.04.014. PMID 19493601. Diarsipkan dari versi aslinya tanggal April 12, 2022. Diakses tanggal October 19, 2020.
Holsboer-Trachsler E, Prieto R (May 1, 2013). "Effects of pregabalin on sleep in generalized anxiety disorder". International Journal of Neuropsychopharmacology. 16 (4): 925–936. doi:10.1017/S1461145712000922. PMID 23009881.
Sills GJ (February 2006). "The mechanisms of action of gabapentin and pregabalin". Current Opinion in Pharmacology. 6 (1): 108–113. doi:10.1016/j.coph.2005.11.003. PMID 16376147.
Bryans JS, Wustrow DJ (March 1999). "3-substituted GABA analogs with central nervous system activity: a review". Medicinal Research Reviews. 19 (2): 149–177. doi:10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B. PMID 10189176. S2CID 38496241.
Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, Cui M, Hoffman D, Donevan S (September 2011). "Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits". European Journal of Pharmacology. 667 (1–3): 80–90. doi:10.1016/j.ejphar.2011.05.054. PMID 21651903. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 20, 2020.
Sze PY (1979). "L-Glutamate Decarboxylase". GABA—Biochemistry and CNS Functions. Advances in Experimental Medicine and Biology. Vol. 123. hlm. 59–78. doi:10.1007/978-1-4899-5199-1_4 (tidak aktif January 31, 2024). ISBN 978-1-4899-5201-1. PMID 390996. Pemeliharaan CS1: DOI nonaktif per Januari 2024 (link)
Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A (June 2013). "The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?". Trends in Pharmacological Sciences. 34 (6): 332–339. doi:10.1016/j.tips.2013.04.001. PMID 23642658.
Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC (May 2007). "Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels". Trends in Pharmacological Sciences. 28 (5): 220–228. doi:10.1016/j.tips.2007.03.005. PMID 17403543. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 19, 2020.
Baidya DK, Agarwal A, Khanna P, Arora MK (July 2011). "Pregabalin in acute and chronic pain". Journal of Anaesthesiology Clinical Pharmacology. 27 (3): 307–314. doi:10.4103/0970-9185.83672. PMC 3161452. PMID 21897498.
Taylor CP, Angelotti T, Fauman E (February 2007). "Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery". Epilepsy Research. 73 (2): 137–150. doi:10.1016/j.eplepsyres.2006.09.008. PMID 17126531. S2CID 54254671. Diarsipkan dari versi aslinya tanggal October 23, 2020. Diakses tanggal October 19, 2020.
Lauria-Horner BA, Pohl RB (April 2003). "Pregabalin: a new anxiolytic". Expert Opinion on Investigational Drugs. 12 (4): 663–672. doi:10.1517/13543784.12.4.663. PMID 12665421. S2CID 36137322.
Dickens D, Webb SD, Antonyuk S, Giannoudis A, Owen A, Rädisch S, Hasnain SS, Pirmohamed M (June 2013). "Transport of gabapentin by LAT1 (SLC7A5)". Biochemical Pharmacology. 85 (11): 1672–1683. doi:10.1016/j.bcp.2013.03.022. PMID 23567998. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 19, 2020.
del Amo EM, Urtti A, Yliperttula M (October 2008). "Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2". European Journal of Pharmaceutical Sciences. 35 (3): 161–174. doi:10.1016/j.ejps.2008.06.015. PMID 18656534.
Geldenhuys WJ, Mohammad AS, Adkins CE, Lockman PR (2015). "Molecular determinants of blood-brain barrier permeation". Therapeutic Delivery. 6 (8): 961–971. doi:10.4155/tde.15.32. PMC 4675962. PMID 26305616.
Müller CE (November 2009). "Prodrug approaches for enhancing the bioavailability of drugs with low solubility". Chemistry & Biodiversity. 6 (11): 2071–2083. doi:10.1002/cbdv.200900114. PMID 19937841. S2CID 32513471.
Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (October 1999). "Selective expression of the large neutral amino acid transporter at the blood-brain barrier". Proceedings of the National Academy of Sciences of the United States of America. 96 (21): 12079–12084. Bibcode:1999PNAS...9612079B. doi:10.1073/pnas.96.21.12079. PMC 18415. PMID 10518579.
Ma J, Björnsson ES, Chalasani N (February 2024). "The Safe Use of Analgesics in Patients with Cirrhosis: A Narrative Review". Am J Med. 137 (2): 99–106. doi:10.1016/j.amjmed.2023.10.022. PMID 37918778. S2CID 264888110.
Yogeeswari P, Ragavendran JV, Sriram D (January 2006). "An update on GABA analogs for CNS drug discovery". Recent Patents on CNS Drug Discovery. 1 (1): 113–118. doi:10.2174/157488906775245291. PMID 18221197.
Rose MA, Kam PC (May 2002). "Gabapentin: pharmacology and its use in pain management". Anaesthesia. 57 (5): 451–462. doi:10.1046/j.0003-2409.2001.02399.x. PMID 11966555. S2CID 27431734.
Chalabianloo F, Schjøtt J (January 2009). "Pregabalin og misbrukspotensial" [Pregabalin and its potential for abuse]. Tidsskrift for den Norske Laegeforening (dalam bahasa Norwegia). 129 (3): 186–187. doi:10.4045/tidsskr.08.0047. PMID 19180163. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
Mayor S (October 2018). "Pregabalin and gabapentin become controlled drugs to cut deaths from misuse". BMJ. 363: k4364. doi:10.1136/bmj.k4364. PMID 30327316. S2CID 53520780. Diarsipkan dari versi aslinya tanggal August 9, 2019. Diakses tanggal February 6, 2019.
Jacoby M (2008). "Financial Windfall from Lyrica". Chemical & Engineering News. 86 (10): 56–61. doi:10.1021/cen-v086n010.p056. Diarsipkan dari versi aslinya tanggal October 26, 2020. Diakses tanggal October 26, 2020.

drugs.com

"Pregabalin". Drugs.com. Diarsipkan dari versi aslinya tanggal August 28, 2019. Diakses tanggal November 7, 2016.
"Pregabalin". The American Society of Health-System Pharmacists. Diarsipkan dari versi aslinya tanggal December 2, 2019. Diakses tanggal February 3, 2019.
"Pregabalin Use During Pregnancy". Drugs.com. Diarsipkan dari versi aslinya tanggal March 21, 2019. Diakses tanggal February 4, 2019.
"Generic Lyrica Availability". Drugs.com. Diarsipkan dari versi aslinya tanggal March 27, 2019. Diakses tanggal February 4, 2019.
"Is Lyrica a controlled substance / Narcotic?". Diarsipkan dari versi aslinya tanggal February 4, 2024. Diakses tanggal May 6, 2024.
"How long does it take for Lyrica to work?". Drugs.com. May 25, 2021. Diarsipkan dari versi aslinya tanggal February 18, 2022. Diakses tanggal February 18, 2022.
"Pregabalin Pregnancy and Breastfeeding Warnings". Diarsipkan dari versi aslinya tanggal March 21, 2019. Diakses tanggal August 29, 2016.
"Lyrica: Package Insert & Prescribing Information". Drugs.com. Diarsipkan dari versi aslinya tanggal August 13, 2017. Diakses tanggal August 18, 2016.
"Pregabalin international brands". Drugs.com. Diarsipkan dari versi aslinya tanggal August 28, 2019. Diakses tanggal October 27, 2017.

drugstorenews.com

Levy S (July 22, 2019), "Nine generic firms get FDA approval for generic Lyrica.", Drug Store News, diarsipkan dari asli tanggal August 5, 2020

espacenet.com

worldwide.espacenet.com

US 6197819B1, Silverman RB, Andruszkiewicz R, "Gamma amino butyric acid analogs and optical isomers", dikeluarkan tanggal March 6, 2001, diberikan kepada Northwestern University Diarsipkan March 21, 2019, di Wayback Machine.

europa.eu

ema.europa.eu

"Summary of product characteristics" (PDF). European Medicines Agency (EMA). March 6, 2013. Diarsipkan (PDF) dari versi aslinya tanggal September 16, 2018. Diakses tanggal May 6, 2013.

fda.gov

"FDA approves first generics of Lyrica". U.S. Food and Drug Administration (FDA) (Press release). September 11, 2019. Diarsipkan dari versi aslinya tanggal June 9, 2020. Diakses tanggal October 27, 2019.
"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). June 29, 2023. Diarsipkan dari versi aslinya tanggal June 29, 2023. Diakses tanggal June 29, 2023.
"Medication Guide (Pfizer Inc.)" (PDF). U.S. Food and Drug Administration (FDA). June 2011. Diarsipkan dari asli (PDF) tanggal September 8, 2011. Diakses tanggal November 6, 2011.
"FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems". U.S. Food and Drug Administration (FDA). December 19, 2019. Diarsipkan dari versi aslinya tanggal December 22, 2019. Diakses tanggal December 21, 2019. Artikel ini mengandung teks dari suatu publikasi yang sekarang berada di domain publik:
"FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems" (PDF). U.S. Food and Drug Administration (FDA). December 19, 2019. Diarsipkan dari versi aslinya tanggal December 22, 2019. Artikel ini mengandung teks dari suatu publikasi yang sekarang berada di domain publik:

accessdata.fda.gov

"Pregabalin ER: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Diarsipkan dari versi aslinya tanggal June 24, 2021. Diakses tanggal June 19, 2021.

federalregister.gov

"Schedules of Controlled Substances: Placement of Pregabalin Into Schedule V". Federal Register. July 28, 2005. Diarsipkan dari versi aslinya tanggal August 2, 2021. Diakses tanggal August 27, 2022.

felleskatalogen.no

"Lyrica". Felleskatalogen (dalam bahasa Norwegia). May 7, 2015. Diarsipkan dari asli tanggal December 23, 2016. Diakses tanggal October 26, 2020.

fiercepharma.com

Bulik BS (March 2016). "AbbVie's Humira, Pfizer's Lyrica kick off 2016 with hefty TV ad spend". FiercePharma. Diarsipkan dari asli tanggal October 29, 2020. Diakses tanggal March 5, 2017.

finnegan.com

"Decision: Pfizer Inc. (PFE) v. Teva Pharmaceuticals USA Inc., 12-1576, U.S. Court of Appeals for the Federal Circuit (Washington)" (PDF). Diarsipkan (PDF) dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.

gov.uk

"Pregabalin and gabapentin to be controlled as Class C drugs". GOV.UK. October 15, 2018. Diarsipkan dari versi aslinya tanggal November 12, 2020. Diakses tanggal April 2, 2020.
"Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971". Diarsipkan dari versi aslinya tanggal February 21, 2024. Diakses tanggal February 21, 2024.
"Pregabalin and gabapentin to be controlled as class C drugs". Diarsipkan dari versi aslinya tanggal November 12, 2020. Diakses tanggal April 2, 2020.
"Pregabalin and gabapentin: proposal to schedule under the Misuse of Drugs Regulations 2001". GOV.UK. November 10, 2017. Diarsipkan dari versi aslinya tanggal January 3, 2020. Diakses tanggal April 2, 2020.
"Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971". GOV.UK. March 29, 2019. Diarsipkan dari versi aslinya tanggal February 21, 2024. Diakses tanggal February 21, 2024.

handle.net

hdl.handle.net

Uchitel OD, Di Guilmi MN, Urbano FJ, Gonzalez-Inchauspe C (2010). "Acute modulation of calcium currents and synaptic transmission by gabapentinoids". Channels. 4 (6): 490–496. doi:10.4161/chan.4.6.12864. hdl:11336/20897. PMID 21150315.
Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J (August 2012). "The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis". Anesthesia and Analgesia. 115 (2): 428–442. doi:10.1213/ANE.0b013e318249d36e. hdl:10315/27968. PMID 22415535. S2CID 18933131.

harvard.edu

ui.adsabs.harvard.edu

Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (October 1999). "Selective expression of the large neutral amino acid transporter at the blood-brain barrier". Proceedings of the National Academy of Sciences of the United States of America. 96 (21): 12079–12084. Bibcode:1999PNAS...9612079B. doi:10.1073/pnas.96.21.12079. PMC 18415. PMID 10518579.

jbc.org

Andruszkiewicz R, Silverman RB (December 1990). "4-Amino-3-alkylbutanoic acids as substrates for gamma-aminobutyric acid aminotransferase". The Journal of Biological Chemistry. 265 (36): 22288–22291. doi:10.1016/S0021-9258(18)45702-X. PMID 2266125. Diarsipkan dari versi aslinya tanggal August 27, 2022. Diakses tanggal August 25, 2016.

localhealthrx.com

"Pregabalin". Lexi-Drugs [database on the Internet. Hudson (OH): Lexi-Comp, Inc. 2007. Diarsipkan dari asli tanggal October 19, 2020. Diakses tanggal October 29, 2015..

medicines.org.uk

"Lyrica Capsules". medicines.org.uk. Diarsipkan dari versi aslinya tanggal October 20, 2020. Diakses tanggal October 19, 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Schifano F (June 2014). "Misuse and abuse of pregabalin and gabapentin: cause for concern?". CNS Drugs. 28 (6): 491–496. doi:10.1007/s40263-014-0164-4. PMID 24760436.
Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, Busch JA, Randinitis EJ, Corrigan BW, Haig GM, Boyd RA, Wesche DL (August 2010). "Clinical pharmacokinetics of pregabalin in healthy volunteers". Journal of Clinical Pharmacology. 50 (8): 941–950. doi:10.1177/0091270009352087. PMID 20147618. S2CID 9905501.
Cross AL, Viswanath O, Sherman AI (July 19, 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 29261857. Diarsipkan dari versi aslinya tanggal August 3, 2022. Diakses tanggal August 27, 2022 – via NCBI Bookshelf.
Frampton JE (September 2014). "Pregabalin: a review of its use in adults with generalized anxiety disorder". CNS Drugs. 28 (9): 835–854. doi:10.1007/s40263-014-0192-0. PMID 25149863. S2CID 5349255.
Iftikhar IH, Alghothani L, Trotti LM (December 2017). "Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis". European Journal of Neurology. 24 (12): 1446–1456. doi:10.1111/ene.13449. PMID 28888061. S2CID 22262972.
Calandre EP, Rico-Villademoros F, Slim M (2016). "Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". Expert Rev Neurother. 16 (11): 1263–1277. doi:10.1080/14737175.2016.1202764. PMID 27345098. S2CID 33200190.
Dooley DJ, Taylor CP, Donevan S, Feltner D (2007). "Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission". Trends Pharmacol. Sci. 28 (2): 75–82. doi:10.1016/j.tips.2006.12.006. PMID 17222465.
Calandre EP, Rico-Villademoros F, Slim M (November 2016). "Alpha₂delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". Expert Review of Neurotherapeutics. 16 (11): 1263–1277. doi:10.1080/14737175.2016.1202764. PMID 27345098. S2CID 33200190.
Uchitel OD, Di Guilmi MN, Urbano FJ, Gonzalez-Inchauspe C (2010). "Acute modulation of calcium currents and synaptic transmission by gabapentinoids". Channels. 4 (6): 490–496. doi:10.4161/chan.4.6.12864. hdl:11336/20897. PMID 21150315.
Mishriky BM, Waldron NH, Habib AS (January 2015). "Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis". British Journal of Anaesthesia. 114 (1): 10–31. doi:10.1093/bja/aeu293. PMID 25209095.
Preuss CV, Kalava A, King KC (2024). Prescription of Controlled Substances: Benefits and Risks. PMID 30726003.
Andruszkiewicz R, Silverman RB (December 1990). "4-Amino-3-alkylbutanoic acids as substrates for gamma-aminobutyric acid aminotransferase". The Journal of Biological Chemistry. 265 (36): 22288–22291. doi:10.1016/S0021-9258(18)45702-X. PMID 2266125. Diarsipkan dari versi aslinya tanggal August 27, 2022. Diakses tanggal August 25, 2016.
Dworkin RH, Kirkpatrick P (June 2005). "Pregabalin". Nature Reviews. Drug Discovery. 4 (6): 455–456. doi:10.1038/nrd1756. PMID 15959952. S2CID 265702200. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
Panebianco M, Bresnahan R, Marson AG (March 2022). "Pregabalin add-on for drug-resistant focal epilepsy". The Cochrane Database of Systematic Reviews. 3 (3): CD005612. doi:10.1002/14651858.CD005612.pub5. PMC 8962962. PMID 35349176.
Zhou Q, Zheng J, Yu L, Jia X (October 2012). "Pregabalin monotherapy for epilepsy". The Cochrane Database of Systematic Reviews. 10: CD009429. doi:10.1002/14651858.CD009429.pub2. PMID 23076957.
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T (September 2010). "EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision". European Journal of Neurology. 17 (9): 1113–1e88. doi:10.1111/j.1468-1331.2010.02999.x. PMID 20402746. S2CID 14236933.
Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA (January 2019). "Pregabalin for neuropathic pain in adults". The Cochrane Database of Systematic Reviews. 1 (1): CD007076. doi:10.1002/14651858.CD007076.pub3. PMC 6353204. PMID 30673120.
Finnerup NB, Sindrup SH, Jensen TS (September 2010). "The evidence for pharmacological treatment of neuropathic pain". Pain. 150 (3): 573–581. doi:10.1016/j.pain.2010.06.019. PMID 20705215. S2CID 29830155.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice AS, Bouhassira D, Bennett DL, Selvarajah D (August 2022). "Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial". Lancet. 400 (10353): 680–690. doi:10.1016/s0140-6736(22)01472-6. PMC 9418415. PMID 36007534.
Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, Rey RD, Schug SA, Jensen TS, Tölle TR, Ushida T, Whalen E (January 2021). "Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration" (PDF). Postgraduate Medicine. 133 (1). Informa UK Limited: 1–9. doi:10.1080/00325481.2020.1857992. PMID 33423590. S2CID 231574963. Diarsipkan (PDF) dari versi aslinya tanggal February 27, 2024. Diakses tanggal February 19, 2024.
Bennett MI, Laird B, van Litsenburg C, Nimour M (November 2013). "Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature". Pain Medicine. 14 (11): 1681–1688. doi:10.1111/pme.12212. PMID 23915361.
Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J (August 2012). "The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis". Anesthesia and Analgesia. 115 (2): 428–442. doi:10.1213/ANE.0b013e318249d36e. hdl:10315/27968. PMID 22415535. S2CID 18933131.
Chaparro LE, Smith SA, Moore RA, Wiffen PJ, Gilron I (July 2013). "Pharmacotherapy for the prevention of chronic pain after surgery in adults". The Cochrane Database of Systematic Reviews. 2021 (7): CD008307. doi:10.1002/14651858.CD008307.pub2. PMC 6481826. PMID 23881791.
Hamilton TW, Strickland LH, Pandit HG (August 2016). "A Meta-Analysis on the Use of Gabapentinoids for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty". The Journal of Bone and Joint Surgery. American Volume. 98 (16): 1340–1350. doi:10.2106/jbjs.15.01202. PMID 27535436. Diarsipkan dari versi aslinya tanggal September 29, 2020. Diakses tanggal August 24, 2020.
Patel R, Dickenson AH (April 2016). "Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain". Pharmacology Research & Perspectives. 4 (2): e00205. doi:10.1002/prp2.205. PMC 4804325. PMID 27069626.
Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N (February 2019). "Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis" (PDF). Lancet. 393 (10173): 768–777. doi:10.1016/S0140-6736(18)31793-8. PMID 30712879. S2CID 72332967. Diarsipkan (PDF) dari versi aslinya tanggal March 13, 2020. Diakses tanggal September 8, 2020.; "Supplemental Appendices" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal March 9, 2020.; "Authors' Reply" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal October 17, 2020.
Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A (March 2022). "Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale". Molecular Psychiatry. 27 (3): 1339–1349. doi:10.1038/s41380-021-01386-6. PMC 9095464. PMID 34819636.
Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A (March 2022). "Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale". Molecular Psychiatry. 27 (3): 1339–1349. doi:10.1038/s41380-021-01386-6. PMC 9095464. PMID 34819636.
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ (June 2012). "Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care" (PDF). International Journal of Psychiatry in Clinical Practice. 16 (2): 77–84. doi:10.3109/13651501.2012.667114. PMID 22540422. S2CID 16253034. Diarsipkan (PDF) dari versi aslinya tanggal April 3, 2018. Diakses tanggal October 16, 2020.
Wensel TM, Powe KW, Cates ME (March 2012). "Pregabalin for the treatment of generalized anxiety disorder". The Annals of Pharmacotherapy. 46 (3): 424–429. doi:10.1345/aph.1Q405. PMID 22395254. S2CID 26320851.
Owen RT (September 2007). "Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety". Drugs of Today. 43 (9): 601–610. doi:10.1358/dot.2007.43.9.1133188. PMID 17940637.
Bandelow B, Wedekind D, Leon T (July 2007). "Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention". Expert Review of Neurotherapeutics. 7 (7): 769–781. doi:10.1586/14737175.7.7.769. PMID 17610384. S2CID 6229344.
Ng QX, Han MX, Teoh SE, Yaow CY, Lim YL, Chee KT (August 2021). "A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder". Pharmaceuticals. 14 (9): 834. doi:10.3390/ph14090834. PMC 8469561. PMID 34577534.
Giménez-Campos MS, Pimenta-Fermisson-Ramos P, Díaz-Cambronero JI, Carbonell-Sanchís R, López-Briz E, Ruíz-García V (January 2022). "A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain". Atencion Primaria. 54 (1). Elsevier BV: 102144. doi:10.1016/j.aprim.2021.102144. PMC 8515246. PMID 34637958.
Shanthanna H, Gilron I, Rajarathinam M, AlAmri R, Kamath S, Thabane L, Devereaux PJ, Bhandari M (August 2017). "Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials". PLOS Medicine. 14 (8): e1002369. doi:10.1371/journal.pmed.1002369. PMC 5557428. PMID 28809936.
Freynhagen R, Backonja M, Schug S, Lyndon G, Parsons B, Watt S, Behar R (December 2016). "Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review". CNS Drugs. 30 (12): 1191–1200. doi:10.1007/s40263-016-0390-z. PMC 5124051. PMID 27848217.
Linde M, Mulleners WM, Chronicle EP, McCrory DC (June 2013). "Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults". The Cochrane Database of Systematic Reviews. 6 (6): CD010609. doi:10.1002/14651858.CD010609. PMC 6599858. PMID 23797675.
Onakpoya IJ, Thomas ET, Lee JJ, Goldacre B, Heneghan CJ (January 2019). "Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials". BMJ Open. 9 (1): e023600. doi:10.1136/bmjopen-2018-023600. PMC 6347863. PMID 30670513.
Tanyıldız B, Kandemir B, Mangan MS, Tangılntız A, Göktaş E, Şimşek S (October 2018). "Bilateral Serous Macular Detachment After Attempted Suicide with Pregabalin". Turkish Journal of Ophthalmology. 48 (5): 254–257. doi:10.4274/tjo.70923. PMC 6216534. PMID 30405948.
Desai A, Kherallah Y, Szabo C, Marawar R (March 2019). "Gabapentin or pregabalin induced myoclonus: A case series and literature review". Journal of Clinical Neuroscience. 61: 225–234. doi:10.1016/j.jocn.2018.09.019. PMID 30381161. S2CID 53165515.
Yoo L, Matalon D, Hoffman RS, Goldfarb DS (December 2009). "Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure" (PDF). American Journal of Kidney Diseases. 54 (6): 1127–1130. CiteSeerX 10.1.1.955.4223. doi:10.1053/j.ajkd.2009.04.014. PMID 19493601. Diarsipkan dari versi aslinya tanggal April 12, 2022. Diakses tanggal October 19, 2020.
Holsboer-Trachsler E, Prieto R (May 1, 2013). "Effects of pregabalin on sleep in generalized anxiety disorder". International Journal of Neuropsychopharmacology. 16 (4): 925–936. doi:10.1017/S1461145712000922. PMID 23009881.
Sills GJ (February 2006). "The mechanisms of action of gabapentin and pregabalin". Current Opinion in Pharmacology. 6 (1): 108–113. doi:10.1016/j.coph.2005.11.003. PMID 16376147.
Bryans JS, Wustrow DJ (March 1999). "3-substituted GABA analogs with central nervous system activity: a review". Medicinal Research Reviews. 19 (2): 149–177. doi:10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B. PMID 10189176. S2CID 38496241.
Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, Cui M, Hoffman D, Donevan S (September 2011). "Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits". European Journal of Pharmacology. 667 (1–3): 80–90. doi:10.1016/j.ejphar.2011.05.054. PMID 21651903. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 20, 2020.
Sze PY (1979). "L-Glutamate Decarboxylase". GABA—Biochemistry and CNS Functions. Advances in Experimental Medicine and Biology. Vol. 123. hlm. 59–78. doi:10.1007/978-1-4899-5199-1_4 (tidak aktif January 31, 2024). ISBN 978-1-4899-5201-1. PMID 390996. Pemeliharaan CS1: DOI nonaktif per Januari 2024 (link)
Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A (June 2013). "The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?". Trends in Pharmacological Sciences. 34 (6): 332–339. doi:10.1016/j.tips.2013.04.001. PMID 23642658.
Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC (May 2007). "Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels". Trends in Pharmacological Sciences. 28 (5): 220–228. doi:10.1016/j.tips.2007.03.005. PMID 17403543. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 19, 2020.
Baidya DK, Agarwal A, Khanna P, Arora MK (July 2011). "Pregabalin in acute and chronic pain". Journal of Anaesthesiology Clinical Pharmacology. 27 (3): 307–314. doi:10.4103/0970-9185.83672. PMC 3161452. PMID 21897498.
Taylor CP, Angelotti T, Fauman E (February 2007). "Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery". Epilepsy Research. 73 (2): 137–150. doi:10.1016/j.eplepsyres.2006.09.008. PMID 17126531. S2CID 54254671. Diarsipkan dari versi aslinya tanggal October 23, 2020. Diakses tanggal October 19, 2020.
Lauria-Horner BA, Pohl RB (April 2003). "Pregabalin: a new anxiolytic". Expert Opinion on Investigational Drugs. 12 (4): 663–672. doi:10.1517/13543784.12.4.663. PMID 12665421. S2CID 36137322.
Dickens D, Webb SD, Antonyuk S, Giannoudis A, Owen A, Rädisch S, Hasnain SS, Pirmohamed M (June 2013). "Transport of gabapentin by LAT1 (SLC7A5)". Biochemical Pharmacology. 85 (11): 1672–1683. doi:10.1016/j.bcp.2013.03.022. PMID 23567998. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 19, 2020.
del Amo EM, Urtti A, Yliperttula M (October 2008). "Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2". European Journal of Pharmaceutical Sciences. 35 (3): 161–174. doi:10.1016/j.ejps.2008.06.015. PMID 18656534.
Geldenhuys WJ, Mohammad AS, Adkins CE, Lockman PR (2015). "Molecular determinants of blood-brain barrier permeation". Therapeutic Delivery. 6 (8): 961–971. doi:10.4155/tde.15.32. PMC 4675962. PMID 26305616.
Müller CE (November 2009). "Prodrug approaches for enhancing the bioavailability of drugs with low solubility". Chemistry & Biodiversity. 6 (11): 2071–2083. doi:10.1002/cbdv.200900114. PMID 19937841. S2CID 32513471.
Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (October 1999). "Selective expression of the large neutral amino acid transporter at the blood-brain barrier". Proceedings of the National Academy of Sciences of the United States of America. 96 (21): 12079–12084. Bibcode:1999PNAS...9612079B. doi:10.1073/pnas.96.21.12079. PMC 18415. PMID 10518579.
Ma J, Björnsson ES, Chalasani N (February 2024). "The Safe Use of Analgesics in Patients with Cirrhosis: A Narrative Review". Am J Med. 137 (2): 99–106. doi:10.1016/j.amjmed.2023.10.022. PMID 37918778. S2CID 264888110.
Yogeeswari P, Ragavendran JV, Sriram D (January 2006). "An update on GABA analogs for CNS drug discovery". Recent Patents on CNS Drug Discovery. 1 (1): 113–118. doi:10.2174/157488906775245291. PMID 18221197.
Rose MA, Kam PC (May 2002). "Gabapentin: pharmacology and its use in pain management". Anaesthesia. 57 (5): 451–462. doi:10.1046/j.0003-2409.2001.02399.x. PMID 11966555. S2CID 27431734.
Chalabianloo F, Schjøtt J (January 2009). "Pregabalin og misbrukspotensial" [Pregabalin and its potential for abuse]. Tidsskrift for den Norske Laegeforening (dalam bahasa Norwegia). 129 (3): 186–187. doi:10.4045/tidsskr.08.0047. PMID 19180163. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
Mayor S (October 2018). "Pregabalin and gabapentin become controlled drugs to cut deaths from misuse". BMJ. 363: k4364. doi:10.1136/bmj.k4364. PMID 30327316. S2CID 53520780. Diarsipkan dari versi aslinya tanggal August 9, 2019. Diakses tanggal February 6, 2019.

ncbi.nlm.nih.gov

Cross AL, Viswanath O, Sherman AI (July 19, 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 29261857. Diarsipkan dari versi aslinya tanggal August 3, 2022. Diakses tanggal August 27, 2022 – via NCBI Bookshelf.
Panebianco M, Bresnahan R, Marson AG (March 2022). "Pregabalin add-on for drug-resistant focal epilepsy". The Cochrane Database of Systematic Reviews. 3 (3): CD005612. doi:10.1002/14651858.CD005612.pub5. PMC 8962962. PMID 35349176.
Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA (January 2019). "Pregabalin for neuropathic pain in adults". The Cochrane Database of Systematic Reviews. 1 (1): CD007076. doi:10.1002/14651858.CD007076.pub3. PMC 6353204. PMID 30673120.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice AS, Bouhassira D, Bennett DL, Selvarajah D (August 2022). "Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial". Lancet. 400 (10353): 680–690. doi:10.1016/s0140-6736(22)01472-6. PMC 9418415. PMID 36007534.
Chaparro LE, Smith SA, Moore RA, Wiffen PJ, Gilron I (July 2013). "Pharmacotherapy for the prevention of chronic pain after surgery in adults". The Cochrane Database of Systematic Reviews. 2021 (7): CD008307. doi:10.1002/14651858.CD008307.pub2. PMC 6481826. PMID 23881791.
Patel R, Dickenson AH (April 2016). "Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain". Pharmacology Research & Perspectives. 4 (2): e00205. doi:10.1002/prp2.205. PMC 4804325. PMID 27069626.
Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A (March 2022). "Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale". Molecular Psychiatry. 27 (3): 1339–1349. doi:10.1038/s41380-021-01386-6. PMC 9095464. PMID 34819636.
Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A (March 2022). "Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale". Molecular Psychiatry. 27 (3): 1339–1349. doi:10.1038/s41380-021-01386-6. PMC 9095464. PMID 34819636.
Ng QX, Han MX, Teoh SE, Yaow CY, Lim YL, Chee KT (August 2021). "A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder". Pharmaceuticals. 14 (9): 834. doi:10.3390/ph14090834. PMC 8469561. PMID 34577534.
Giménez-Campos MS, Pimenta-Fermisson-Ramos P, Díaz-Cambronero JI, Carbonell-Sanchís R, López-Briz E, Ruíz-García V (January 2022). "A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain". Atencion Primaria. 54 (1). Elsevier BV: 102144. doi:10.1016/j.aprim.2021.102144. PMC 8515246. PMID 34637958.
Shanthanna H, Gilron I, Rajarathinam M, AlAmri R, Kamath S, Thabane L, Devereaux PJ, Bhandari M (August 2017). "Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials". PLOS Medicine. 14 (8): e1002369. doi:10.1371/journal.pmed.1002369. PMC 5557428. PMID 28809936.
Freynhagen R, Backonja M, Schug S, Lyndon G, Parsons B, Watt S, Behar R (December 2016). "Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review". CNS Drugs. 30 (12): 1191–1200. doi:10.1007/s40263-016-0390-z. PMC 5124051. PMID 27848217.
Linde M, Mulleners WM, Chronicle EP, McCrory DC (June 2013). "Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults". The Cochrane Database of Systematic Reviews. 6 (6): CD010609. doi:10.1002/14651858.CD010609. PMC 6599858. PMID 23797675.
Onakpoya IJ, Thomas ET, Lee JJ, Goldacre B, Heneghan CJ (January 2019). "Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials". BMJ Open. 9 (1): e023600. doi:10.1136/bmjopen-2018-023600. PMC 6347863. PMID 30670513.
Tanyıldız B, Kandemir B, Mangan MS, Tangılntız A, Göktaş E, Şimşek S (October 2018). "Bilateral Serous Macular Detachment After Attempted Suicide with Pregabalin". Turkish Journal of Ophthalmology. 48 (5): 254–257. doi:10.4274/tjo.70923. PMC 6216534. PMID 30405948.
Baidya DK, Agarwal A, Khanna P, Arora MK (July 2011). "Pregabalin in acute and chronic pain". Journal of Anaesthesiology Clinical Pharmacology. 27 (3): 307–314. doi:10.4103/0970-9185.83672. PMC 3161452. PMID 21897498.
Geldenhuys WJ, Mohammad AS, Adkins CE, Lockman PR (2015). "Molecular determinants of blood-brain barrier permeation". Therapeutic Delivery. 6 (8): 961–971. doi:10.4155/tde.15.32. PMC 4675962. PMID 26305616.
Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (October 1999). "Selective expression of the large neutral amino acid transporter at the blood-brain barrier". Proceedings of the National Academy of Sciences of the United States of America. 96 (21): 12079–12084. Bibcode:1999PNAS...9612079B. doi:10.1073/pnas.96.21.12079. PMC 18415. PMID 10518579.

dailymed.nlm.nih.gov

"Lyrica- pregabalin capsule Lyrica- pregabalin solution". DailyMed. June 15, 2020. Diarsipkan dari versi aslinya tanggal September 25, 2021. Diakses tanggal August 27, 2022.

nihr.ac.uk

evidence.nihr.ac.uk

"Combination therapy for painful diabetic neuropathy is safe and effective". NIHR Evidence (dalam bahasa Inggris). April 6, 2023. doi:10.3310/nihrevidence_57470. S2CID 258013544. Diarsipkan dari versi aslinya tanggal April 28, 2023. Diakses tanggal April 28, 2023.
"Review finds little evidence to support gabapentinoid use in bipolar disorder or insomnia". NIHR Evidence (Plain English summary) (dalam bahasa Inggris). National Institute for Health and Care Research. October 17, 2022. doi:10.3310/nihrevidence_54173. S2CID 252983016. Diarsipkan dari versi aslinya tanggal November 27, 2022. Diakses tanggal October 27, 2022.

northbynorthwestern.com

Merrill N (February 25, 2010). "Silverman's golden drug makes him NU's golden ticket". North by Northwestern. Diarsipkan dari asli tanggal June 1, 2016. Diakses tanggal May 19, 2016.

nytimes.com

Harris G (September 2, 2009). "Pfizer Pays $2.3 Billion to Settle Marketing Case". The New York Times. Diarsipkan dari versi aslinya tanggal September 26, 2020. Diakses tanggal December 21, 2017.

ox.ac.uk

ora.ox.ac.uk

Hamilton TW, Strickland LH, Pandit HG (August 2016). "A Meta-Analysis on the Use of Gabapentinoids for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty". The Journal of Bone and Joint Surgery. American Volume. 98 (16): 1340–1350. doi:10.2106/jbjs.15.01202. PMID 27535436. Diarsipkan dari versi aslinya tanggal September 29, 2020. Diakses tanggal August 24, 2020.

pap.pl

scienceinpoland.pap.pl

Poros J (2005). "Polish scientist is the co-author of a new anti-epileptic drug". Science and Scholarship in Poland. Diarsipkan dari asli tanggal August 20, 2016. Diakses tanggal May 19, 2016.

pfizer.com.au

Lyrica (Australian Approved Product Information), Pfizer Australia Pty Ltd., 2006, diarsipkan dari asli tanggal March 13, 2018

prnewswire.com

"Pfizer's Lyrica Approved for the Treatment of Generalized Anxiety Disorder (GAD) in Europe" (Press release). Diarsipkan dari asli tanggal September 29, 2007. Diakses tanggal November 6, 2011.

psu.edu

citeseerx.ist.psu.edu

Yoo L, Matalon D, Hoffman RS, Goldfarb DS (December 2009). "Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure" (PDF). American Journal of Kidney Diseases. 54 (6): 1127–1130. CiteSeerX 10.1.1.955.4223. doi:10.1053/j.ajkd.2009.04.014. PMID 19493601. Diarsipkan dari versi aslinya tanggal April 12, 2022. Diakses tanggal October 19, 2020.

publishing.service.gov.uk

assets.publishing.service.gov.uk

"Re: Pregabalin and Gabapentin advice" (PDF). GOV.UK. January 14, 2016. Diarsipkan (PDF) dari versi aslinya tanggal November 8, 2020. Diakses tanggal February 6, 2019.

pulsetoday.co.uk

"Pfizer's failed pregabalin patent appeal means NHS could reclaim £502m". Pulse. November 14, 2018. Diarsipkan dari asli tanggal November 15, 2018. Diakses tanggal May 17, 2024.

recovered.org

"Is Lyrica a Controlled Substance?". Diarsipkan dari versi aslinya tanggal May 6, 2024. Diakses tanggal May 6, 2024.

release.org.uk

"Controlled Drug Classes". August 12, 2013. Diarsipkan dari versi aslinya tanggal March 28, 2024. Diakses tanggal May 6, 2024.

reuters.com

"BRIEF-FDA approves Pfizer's Lyrica CR extended-release tablets CV". Reuters. Diarsipkan dari versi aslinya tanggal October 4, 2018. Diakses tanggal October 3, 2018.

scholar.google.com

Dworkin RH, Kirkpatrick P (June 2005). "Pregabalin". Nature Reviews. Drug Discovery. 4 (6): 455–456. doi:10.1038/nrd1756. PMID 15959952. S2CID 265702200. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, Cui M, Hoffman D, Donevan S (September 2011). "Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits". European Journal of Pharmacology. 667 (1–3): 80–90. doi:10.1016/j.ejphar.2011.05.054. PMID 21651903. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 20, 2020.
Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC (May 2007). "Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels". Trends in Pharmacological Sciences. 28 (5): 220–228. doi:10.1016/j.tips.2007.03.005. PMID 17403543. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 19, 2020.
Taylor CP, Angelotti T, Fauman E (February 2007). "Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery". Epilepsy Research. 73 (2): 137–150. doi:10.1016/j.eplepsyres.2006.09.008. PMID 17126531. S2CID 54254671. Diarsipkan dari versi aslinya tanggal October 23, 2020. Diakses tanggal October 19, 2020.
Dickens D, Webb SD, Antonyuk S, Giannoudis A, Owen A, Rädisch S, Hasnain SS, Pirmohamed M (June 2013). "Transport of gabapentin by LAT1 (SLC7A5)". Biochemical Pharmacology. 85 (11): 1672–1683. doi:10.1016/j.bcp.2013.03.022. PMID 23567998. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 19, 2020.

science.org

Lowe D (March 25, 2008). "Getting to Lyrica". In the Pipeline. Science. Diarsipkan dari versi aslinya tanggal August 27, 2022. Diakses tanggal November 21, 2015.

sec.gov

"Portions of the Pfizer Inc. 2010 Financial Report". U.S. Securities and Exchange Commission. 2010. Diarsipkan dari versi aslinya tanggal June 10, 2019. Diakses tanggal December 21, 2017.

seekingalpha.com

"FDA approves LYRICA CR extended-release tablets CV". Seeking Alpha. October 12, 2017. Diarsipkan dari versi aslinya tanggal September 20, 2022. Diakses tanggal September 16, 2022.

semanticscholar.org

api.semanticscholar.org

Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, Busch JA, Randinitis EJ, Corrigan BW, Haig GM, Boyd RA, Wesche DL (August 2010). "Clinical pharmacokinetics of pregabalin in healthy volunteers". Journal of Clinical Pharmacology. 50 (8): 941–950. doi:10.1177/0091270009352087. PMID 20147618. S2CID 9905501.
Frampton JE (September 2014). "Pregabalin: a review of its use in adults with generalized anxiety disorder". CNS Drugs. 28 (9): 835–854. doi:10.1007/s40263-014-0192-0. PMID 25149863. S2CID 5349255.
Iftikhar IH, Alghothani L, Trotti LM (December 2017). "Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis". European Journal of Neurology. 24 (12): 1446–1456. doi:10.1111/ene.13449. PMID 28888061. S2CID 22262972.
Calandre EP, Rico-Villademoros F, Slim M (2016). "Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". Expert Rev Neurother. 16 (11): 1263–1277. doi:10.1080/14737175.2016.1202764. PMID 27345098. S2CID 33200190.
Calandre EP, Rico-Villademoros F, Slim M (November 2016). "Alpha₂delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". Expert Review of Neurotherapeutics. 16 (11): 1263–1277. doi:10.1080/14737175.2016.1202764. PMID 27345098. S2CID 33200190.
Dworkin RH, Kirkpatrick P (June 2005). "Pregabalin". Nature Reviews. Drug Discovery. 4 (6): 455–456. doi:10.1038/nrd1756. PMID 15959952. S2CID 265702200. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T (September 2010). "EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision". European Journal of Neurology. 17 (9): 1113–1e88. doi:10.1111/j.1468-1331.2010.02999.x. PMID 20402746. S2CID 14236933.
Finnerup NB, Sindrup SH, Jensen TS (September 2010). "The evidence for pharmacological treatment of neuropathic pain". Pain. 150 (3): 573–581. doi:10.1016/j.pain.2010.06.019. PMID 20705215. S2CID 29830155.
"Combination therapy for painful diabetic neuropathy is safe and effective". NIHR Evidence (dalam bahasa Inggris). April 6, 2023. doi:10.3310/nihrevidence_57470. S2CID 258013544. Diarsipkan dari versi aslinya tanggal April 28, 2023. Diakses tanggal April 28, 2023.
Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, Rey RD, Schug SA, Jensen TS, Tölle TR, Ushida T, Whalen E (January 2021). "Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration" (PDF). Postgraduate Medicine. 133 (1). Informa UK Limited: 1–9. doi:10.1080/00325481.2020.1857992. PMID 33423590. S2CID 231574963. Diarsipkan (PDF) dari versi aslinya tanggal February 27, 2024. Diakses tanggal February 19, 2024.
Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J (August 2012). "The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis". Anesthesia and Analgesia. 115 (2): 428–442. doi:10.1213/ANE.0b013e318249d36e. hdl:10315/27968. PMID 22415535. S2CID 18933131.
Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N (February 2019). "Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis" (PDF). Lancet. 393 (10173): 768–777. doi:10.1016/S0140-6736(18)31793-8. PMID 30712879. S2CID 72332967. Diarsipkan (PDF) dari versi aslinya tanggal March 13, 2020. Diakses tanggal September 8, 2020.; "Supplemental Appendices" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal March 9, 2020.; "Authors' Reply" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal October 17, 2020.
"Review finds little evidence to support gabapentinoid use in bipolar disorder or insomnia". NIHR Evidence (Plain English summary) (dalam bahasa Inggris). National Institute for Health and Care Research. October 17, 2022. doi:10.3310/nihrevidence_54173. S2CID 252983016. Diarsipkan dari versi aslinya tanggal November 27, 2022. Diakses tanggal October 27, 2022.
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ (June 2012). "Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care" (PDF). International Journal of Psychiatry in Clinical Practice. 16 (2): 77–84. doi:10.3109/13651501.2012.667114. PMID 22540422. S2CID 16253034. Diarsipkan (PDF) dari versi aslinya tanggal April 3, 2018. Diakses tanggal October 16, 2020.
Wensel TM, Powe KW, Cates ME (March 2012). "Pregabalin for the treatment of generalized anxiety disorder". The Annals of Pharmacotherapy. 46 (3): 424–429. doi:10.1345/aph.1Q405. PMID 22395254. S2CID 26320851.
Bandelow B, Wedekind D, Leon T (July 2007). "Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention". Expert Review of Neurotherapeutics. 7 (7): 769–781. doi:10.1586/14737175.7.7.769. PMID 17610384. S2CID 6229344.
Slocum GW, Schult RF, Gorodetsky RM, Wiegand TJ, Kamali M, Acquisto NM (January 1, 2018). "Pregabalin and paradoxical reaction of seizures in a large overdose". Toxicology Communications. 2 (1): 19–20. doi:10.1080/24734306.2018.1458465. S2CID 79760296.
Millar J, Sadasivan S, Weatherup N, Lutton S (September 7, 2013). "Lyrica Nights–Recreational Pregabalin Abuse in an Urban Emergency Department". Emergency Medicine Journal. 30 (10): 874.2–874. doi:10.1136/emermed-2013-203113.20. S2CID 73986091.
Desai A, Kherallah Y, Szabo C, Marawar R (March 2019). "Gabapentin or pregabalin induced myoclonus: A case series and literature review". Journal of Clinical Neuroscience. 61: 225–234. doi:10.1016/j.jocn.2018.09.019. PMID 30381161. S2CID 53165515.
Murphy NG, Mosher L (2008). "79. Severe myoclonus from pregabalin (Lyrica) due to chronic renal insufficiency". Clinical Toxicology. 46 (7): 604. doi:10.1080/15563650802255033. S2CID 218857181.
Bryans JS, Wustrow DJ (March 1999). "3-substituted GABA analogs with central nervous system activity: a review". Medicinal Research Reviews. 19 (2): 149–177. doi:10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B. PMID 10189176. S2CID 38496241.
Taylor CP, Angelotti T, Fauman E (February 2007). "Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery". Epilepsy Research. 73 (2): 137–150. doi:10.1016/j.eplepsyres.2006.09.008. PMID 17126531. S2CID 54254671. Diarsipkan dari versi aslinya tanggal October 23, 2020. Diakses tanggal October 19, 2020.
Lauria-Horner BA, Pohl RB (April 2003). "Pregabalin: a new anxiolytic". Expert Opinion on Investigational Drugs. 12 (4): 663–672. doi:10.1517/13543784.12.4.663. PMID 12665421. S2CID 36137322.
Müller CE (November 2009). "Prodrug approaches for enhancing the bioavailability of drugs with low solubility". Chemistry & Biodiversity. 6 (11): 2071–2083. doi:10.1002/cbdv.200900114. PMID 19937841. S2CID 32513471.
Ma J, Björnsson ES, Chalasani N (February 2024). "The Safe Use of Analgesics in Patients with Cirrhosis: A Narrative Review". Am J Med. 137 (2): 99–106. doi:10.1016/j.amjmed.2023.10.022. PMID 37918778. S2CID 264888110.
Rose MA, Kam PC (May 2002). "Gabapentin: pharmacology and its use in pain management". Anaesthesia. 57 (5): 451–462. doi:10.1046/j.0003-2409.2001.02399.x. PMID 11966555. S2CID 27431734.
Mayor S (October 2018). "Pregabalin and gabapentin become controlled drugs to cut deaths from misuse". BMJ. 363: k4364. doi:10.1136/bmj.k4364. PMID 30327316. S2CID 53520780. Diarsipkan dari versi aslinya tanggal August 9, 2019. Diakses tanggal February 6, 2019.

stopmedicarefraud.gov

"Pfizer to pay $2.3 billion to resolve criminal and civil health care liability relating to fraudulent marketing and the payment of kickbacks". Stop Medicare Fraud, U.S. Departments of Health & Human Services, and of Justice. Diarsipkan dari asli tanggal August 30, 2012. Diakses tanggal July 4, 2012.

tidsskriftet.no

Chalabianloo F, Schjøtt J (January 2009). "Pregabalin og misbrukspotensial" [Pregabalin and its potential for abuse]. Tidsskrift for den Norske Laegeforening (dalam bahasa Norwegia). 129 (3): 186–187. doi:10.4045/tidsskr.08.0047. PMID 19180163. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.

ucl.ac.uk

discovery.ucl.ac.uk

Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N (February 2019). "Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis" (PDF). Lancet. 393 (10173): 768–777. doi:10.1016/S0140-6736(18)31793-8. PMID 30712879. S2CID 72332967. Diarsipkan (PDF) dari versi aslinya tanggal March 13, 2020. Diakses tanggal September 8, 2020.; "Supplemental Appendices" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal March 9, 2020.; "Authors' Reply" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal October 17, 2020.

usdoj.gov

deadiversion.usdoj.gov

"2005 - Placement of Pregabalin Into Schedule V". DEA Diversion Control Division. July 28, 2005. Diarsipkan dari versi aslinya tanggal May 28, 2022. Diakses tanggal August 27, 2022.
"Title 21 CFR – PART 1308 – Section 1308.15 Schedule V". usdoj.gov. Diarsipkan dari asli tanggal September 3, 2020. Diakses tanggal September 27, 2015.

web.archive.org

"Pregabalin". Drugs.com. Diarsipkan dari versi aslinya tanggal August 28, 2019. Diakses tanggal November 7, 2016.
"Summary of product characteristics" (PDF). European Medicines Agency (EMA). March 6, 2013. Diarsipkan (PDF) dari versi aslinya tanggal September 16, 2018. Diakses tanggal May 6, 2013.
Expert Committee on Drug Dependence Forty-first Meeting (November 2018). Critical Review Report: Pregabalin (PDF) (Report). Geneva: World Health Organization. Diarsipkan dari asli (PDF) tanggal October 26, 2020.
Cross AL, Viswanath O, Sherman AI (July 19, 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 29261857. Diarsipkan dari versi aslinya tanggal August 3, 2022. Diakses tanggal August 27, 2022 – via NCBI Bookshelf.
"Pregabalin". The American Society of Health-System Pharmacists. Diarsipkan dari versi aslinya tanggal December 2, 2019. Diakses tanggal February 3, 2019.
Frye M, Moore K (2009). "Gabapentin and Pregabalin". Dalam Schatzberg AF, Nemeroff CB (ed.). The American Psychiatric Publishing Textbook of Psychopharmacology. hlm. 767–77. doi:10.1176/appi.books.9781585623860.as38. ISBN 978-1-58562-309-9. Diarsipkan dari versi aslinya tanggal February 27, 2024. Diakses tanggal September 1, 2022.
"Pregabalin Use During Pregnancy". Drugs.com. Diarsipkan dari versi aslinya tanggal March 21, 2019. Diakses tanggal February 4, 2019.
Kaye AD, Vadivelu N, Urman RD (2014). Substance Abuse: Inpatient and Outpatient Management for Every Clinician. Springer. hlm. 324. ISBN 9781493919512. Diarsipkan dari versi aslinya tanggal March 1, 2022. Diakses tanggal August 24, 2020.
"Generic Lyrica Availability". Drugs.com. Diarsipkan dari versi aslinya tanggal March 27, 2019. Diakses tanggal February 4, 2019.
"FDA approves first generics of Lyrica". U.S. Food and Drug Administration (FDA) (Press release). September 11, 2019. Diarsipkan dari versi aslinya tanggal June 9, 2020. Diakses tanggal October 27, 2019.
"Pregabalin ER: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Diarsipkan dari versi aslinya tanggal June 24, 2021. Diakses tanggal June 19, 2021.
"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). June 29, 2023. Diarsipkan dari versi aslinya tanggal June 29, 2023. Diakses tanggal June 29, 2023.
"Is Lyrica a Controlled Substance?". Diarsipkan dari versi aslinya tanggal May 6, 2024. Diakses tanggal May 6, 2024.
"Is Lyrica a controlled substance / Narcotic?". Diarsipkan dari versi aslinya tanggal February 4, 2024. Diakses tanggal May 6, 2024.
"Pregabalin and gabapentin to be controlled as Class C drugs". GOV.UK. October 15, 2018. Diarsipkan dari versi aslinya tanggal November 12, 2020. Diakses tanggal April 2, 2020.
"Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971". Diarsipkan dari versi aslinya tanggal February 21, 2024. Diakses tanggal February 21, 2024.
"Controlled Drug Classes". August 12, 2013. Diarsipkan dari versi aslinya tanggal March 28, 2024. Diakses tanggal May 6, 2024.
"What are Class C Drugs?". October 31, 2022. Diarsipkan dari versi aslinya tanggal May 6, 2024. Diakses tanggal May 6, 2024.
"Pregabalin and gabapentin to be controlled as class C drugs". Diarsipkan dari versi aslinya tanggal November 12, 2020. Diakses tanggal April 2, 2020.
Lowe D (March 25, 2008). "Getting to Lyrica". In the Pipeline. Science. Diarsipkan dari versi aslinya tanggal August 27, 2022. Diakses tanggal November 21, 2015.
Merrill N (February 25, 2010). "Silverman's golden drug makes him NU's golden ticket". North by Northwestern. Diarsipkan dari asli tanggal June 1, 2016. Diakses tanggal May 19, 2016.
Andruszkiewicz R, Silverman RB (December 1990). "4-Amino-3-alkylbutanoic acids as substrates for gamma-aminobutyric acid aminotransferase". The Journal of Biological Chemistry. 265 (36): 22288–22291. doi:10.1016/S0021-9258(18)45702-X. PMID 2266125. Diarsipkan dari versi aslinya tanggal August 27, 2022. Diakses tanggal August 25, 2016.
Poros J (2005). "Polish scientist is the co-author of a new anti-epileptic drug". Science and Scholarship in Poland. Diarsipkan dari asli tanggal August 20, 2016. Diakses tanggal May 19, 2016.
Dworkin RH, Kirkpatrick P (June 2005). "Pregabalin". Nature Reviews. Drug Discovery. 4 (6): 455–456. doi:10.1038/nrd1756. PMID 15959952. S2CID 265702200. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
"FDA approves LYRICA CR extended-release tablets CV". Seeking Alpha. October 12, 2017. Diarsipkan dari versi aslinya tanggal September 20, 2022. Diakses tanggal September 16, 2022.
"BRIEF-FDA approves Pfizer's Lyrica CR extended-release tablets CV". Reuters. Diarsipkan dari versi aslinya tanggal October 4, 2018. Diakses tanggal October 3, 2018.
"Lyrica- pregabalin capsule Lyrica- pregabalin solution". DailyMed. June 15, 2020. Diarsipkan dari versi aslinya tanggal September 25, 2021. Diakses tanggal August 27, 2022.
"Combination therapy for painful diabetic neuropathy is safe and effective". NIHR Evidence (dalam bahasa Inggris). April 6, 2023. doi:10.3310/nihrevidence_57470. S2CID 258013544. Diarsipkan dari versi aslinya tanggal April 28, 2023. Diakses tanggal April 28, 2023.
Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, Rey RD, Schug SA, Jensen TS, Tölle TR, Ushida T, Whalen E (January 2021). "Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration" (PDF). Postgraduate Medicine. 133 (1). Informa UK Limited: 1–9. doi:10.1080/00325481.2020.1857992. PMID 33423590. S2CID 231574963. Diarsipkan (PDF) dari versi aslinya tanggal February 27, 2024. Diakses tanggal February 19, 2024.
Hamilton TW, Strickland LH, Pandit HG (August 2016). "A Meta-Analysis on the Use of Gabapentinoids for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty". The Journal of Bone and Joint Surgery. American Volume. 98 (16): 1340–1350. doi:10.2106/jbjs.15.01202. PMID 27535436. Diarsipkan dari versi aslinya tanggal September 29, 2020. Diakses tanggal August 24, 2020.
Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N (February 2019). "Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis" (PDF). Lancet. 393 (10173): 768–777. doi:10.1016/S0140-6736(18)31793-8. PMID 30712879. S2CID 72332967. Diarsipkan (PDF) dari versi aslinya tanggal March 13, 2020. Diakses tanggal September 8, 2020.; "Supplemental Appendices" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal March 9, 2020.; "Authors' Reply" (PDF). June 5, 2018. Diarsipkan dari asli (PDF) tanggal October 17, 2020.
"Review finds little evidence to support gabapentinoid use in bipolar disorder or insomnia". NIHR Evidence (Plain English summary) (dalam bahasa Inggris). National Institute for Health and Care Research. October 17, 2022. doi:10.3310/nihrevidence_54173. S2CID 252983016. Diarsipkan dari versi aslinya tanggal November 27, 2022. Diakses tanggal October 27, 2022.
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ (June 2012). "Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care" (PDF). International Journal of Psychiatry in Clinical Practice. 16 (2): 77–84. doi:10.3109/13651501.2012.667114. PMID 22540422. S2CID 16253034. Diarsipkan (PDF) dari versi aslinya tanggal April 3, 2018. Diakses tanggal October 16, 2020.
"How long does it take for Lyrica to work?". Drugs.com. May 25, 2021. Diarsipkan dari versi aslinya tanggal February 18, 2022. Diakses tanggal February 18, 2022.
Mannix L (December 18, 2018). "This popular drug is linked to addiction and suicide. Why do doctors keep prescribing it?". The Canberra Times. Diarsipkan dari asli tanggal December 18, 2018. Diakses tanggal December 18, 2018.
"Schedules of Controlled Substances: Placement of Pregabalin Into Schedule V". Federal Register. July 28, 2005. Diarsipkan dari versi aslinya tanggal August 2, 2021. Diakses tanggal August 27, 2022.
Lyrica (Australian Approved Product Information), Pfizer Australia Pty Ltd., 2006, diarsipkan dari asli tanggal March 13, 2018
"Medication Guide (Pfizer Inc.)" (PDF). U.S. Food and Drug Administration (FDA). June 2011. Diarsipkan dari asli (PDF) tanggal September 8, 2011. Diakses tanggal November 6, 2011.
"Lyrica Capsules". medicines.org.uk. Diarsipkan dari versi aslinya tanggal October 20, 2020. Diakses tanggal October 19, 2020.
"Pregabalin Pregnancy and Breastfeeding Warnings". Diarsipkan dari versi aslinya tanggal March 21, 2019. Diakses tanggal August 29, 2016.
"FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems". U.S. Food and Drug Administration (FDA). December 19, 2019. Diarsipkan dari versi aslinya tanggal December 22, 2019. Diakses tanggal December 21, 2019. Artikel ini mengandung teks dari suatu publikasi yang sekarang berada di domain publik:
"FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems" (PDF). U.S. Food and Drug Administration (FDA). December 19, 2019. Diarsipkan dari versi aslinya tanggal December 22, 2019. Artikel ini mengandung teks dari suatu publikasi yang sekarang berada di domain publik:
Yoo L, Matalon D, Hoffman RS, Goldfarb DS (December 2009). "Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure" (PDF). American Journal of Kidney Diseases. 54 (6): 1127–1130. CiteSeerX 10.1.1.955.4223. doi:10.1053/j.ajkd.2009.04.014. PMID 19493601. Diarsipkan dari versi aslinya tanggal April 12, 2022. Diakses tanggal October 19, 2020.
"Pregabalin". Lexi-Drugs [database on the Internet. Hudson (OH): Lexi-Comp, Inc. 2007. Diarsipkan dari asli tanggal October 19, 2020. Diakses tanggal October 29, 2015..
Lin GQ, You QD, Cheng JF, ed. (August 8, 2011). Chiral Drugs: Chemistry and Biological Action. John Wiley & Sons. hlm. 88. ISBN 9781118075630. Diarsipkan dari versi aslinya tanggal April 25, 2022. Diakses tanggal August 17, 2016 – via Google Books.
Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, Cui M, Hoffman D, Donevan S (September 2011). "Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits". European Journal of Pharmacology. 667 (1–3): 80–90. doi:10.1016/j.ejphar.2011.05.054. PMID 21651903. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 20, 2020.
Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC (May 2007). "Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels". Trends in Pharmacological Sciences. 28 (5): 220–228. doi:10.1016/j.tips.2007.03.005. PMID 17403543. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 19, 2020.
Taylor CP, Angelotti T, Fauman E (February 2007). "Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery". Epilepsy Research. 73 (2): 137–150. doi:10.1016/j.eplepsyres.2006.09.008. PMID 17126531. S2CID 54254671. Diarsipkan dari versi aslinya tanggal October 23, 2020. Diakses tanggal October 19, 2020.
Dickens D, Webb SD, Antonyuk S, Giannoudis A, Owen A, Rädisch S, Hasnain SS, Pirmohamed M (June 2013). "Transport of gabapentin by LAT1 (SLC7A5)". Biochemical Pharmacology. 85 (11): 1672–1683. doi:10.1016/j.bcp.2013.03.022. PMID 23567998. Diarsipkan dari versi aslinya tanggal October 21, 2020. Diakses tanggal October 19, 2020.
Vardanyan R, Hruby V (January 7, 2016). Synthesis of Best-Seller Drugs. Elsevier Science. hlm. 158. ISBN 978-0-12-411524-8. Diarsipkan dari versi aslinya tanggal August 29, 2021. Diakses tanggal June 22, 2018.
Andrushko V, Andrushko N (August 16, 2013). Stereoselective Synthesis of Drugs and Natural Products. John Wiley & Sons. hlm. 869. ISBN 978-1-118-62833-1. Diarsipkan dari versi aslinya tanggal August 29, 2021. Diakses tanggal June 22, 2018.
"Lyrica: Package Insert & Prescribing Information". Drugs.com. Diarsipkan dari versi aslinya tanggal August 13, 2017. Diakses tanggal August 18, 2016.
"2005 - Placement of Pregabalin Into Schedule V". DEA Diversion Control Division. July 28, 2005. Diarsipkan dari versi aslinya tanggal May 28, 2022. Diakses tanggal August 27, 2022.
"Title 21 CFR – PART 1308 – Section 1308.15 Schedule V". usdoj.gov. Diarsipkan dari asli tanggal September 3, 2020. Diakses tanggal September 27, 2015.
"Lyrica". Felleskatalogen (dalam bahasa Norwegia). May 7, 2015. Diarsipkan dari asli tanggal December 23, 2016. Diakses tanggal October 26, 2020.
Chalabianloo F, Schjøtt J (January 2009). "Pregabalin og misbrukspotensial" [Pregabalin and its potential for abuse]. Tidsskrift for den Norske Laegeforening (dalam bahasa Norwegia). 129 (3): 186–187. doi:10.4045/tidsskr.08.0047. PMID 19180163. Diarsipkan dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
"Re: Pregabalin and Gabapentin advice" (PDF). GOV.UK. January 14, 2016. Diarsipkan (PDF) dari versi aslinya tanggal November 8, 2020. Diakses tanggal February 6, 2019.
"Pregabalin and gabapentin: proposal to schedule under the Misuse of Drugs Regulations 2001". GOV.UK. November 10, 2017. Diarsipkan dari versi aslinya tanggal January 3, 2020. Diakses tanggal April 2, 2020.
Mayor S (October 2018). "Pregabalin and gabapentin become controlled drugs to cut deaths from misuse". BMJ. 363: k4364. doi:10.1136/bmj.k4364. PMID 30327316. S2CID 53520780. Diarsipkan dari versi aslinya tanggal August 9, 2019. Diakses tanggal February 6, 2019.
"Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971". GOV.UK. March 29, 2019. Diarsipkan dari versi aslinya tanggal February 21, 2024. Diakses tanggal February 21, 2024.
"Pfizer to pay $2.3 billion to resolve criminal and civil health care liability relating to fraudulent marketing and the payment of kickbacks". Stop Medicare Fraud, U.S. Departments of Health & Human Services, and of Justice. Diarsipkan dari asli tanggal August 30, 2012. Diakses tanggal July 4, 2012.
Levy S (July 22, 2019), "Nine generic firms get FDA approval for generic Lyrica.", Drug Store News, diarsipkan dari asli tanggal August 5, 2020
"Pfizer's Lyrica Approved for the Treatment of Generalized Anxiety Disorder (GAD) in Europe" (Press release). Diarsipkan dari asli tanggal September 29, 2007. Diakses tanggal November 6, 2011.
"Generic Lyrica launches at 97% discount to brand version". 46brooklyn Research. July 23, 2019. Diarsipkan dari versi aslinya tanggal July 16, 2020. Diakses tanggal December 25, 2019.
Bulik BS (March 2016). "AbbVie's Humira, Pfizer's Lyrica kick off 2016 with hefty TV ad spend". FiercePharma. Diarsipkan dari asli tanggal October 29, 2020. Diakses tanggal March 5, 2017.
Harris G (September 2, 2009). "Pfizer Pays $2.3 Billion to Settle Marketing Case". The New York Times. Diarsipkan dari versi aslinya tanggal September 26, 2020. Diakses tanggal December 21, 2017.
"Pfizer agrees record fraud fine". BBC News. September 2, 2009. Diarsipkan dari versi aslinya tanggal September 8, 2009. Diakses tanggal December 21, 2017.
"Portions of the Pfizer Inc. 2010 Financial Report". U.S. Securities and Exchange Commission. 2010. Diarsipkan dari versi aslinya tanggal June 10, 2019. Diakses tanggal December 21, 2017.
Jacoby M (2008). "Financial Windfall from Lyrica". Chemical & Engineering News. 86 (10): 56–61. doi:10.1021/cen-v086n010.p056. Diarsipkan dari versi aslinya tanggal October 26, 2020. Diakses tanggal October 26, 2020.
US 6197819B1, Silverman RB, Andruszkiewicz R, "Gamma amino butyric acid analogs and optical isomers", dikeluarkan tanggal March 6, 2001, diberikan kepada Northwestern University Diarsipkan March 21, 2019, di Wayback Machine.
Decker S (February 6, 2014). "Pfizer Wins Ruling to Block Generic Lyrica Until 2018". Bloomberg. Diarsipkan dari versi aslinya tanggal February 8, 2014. Diakses tanggal October 26, 2020.
"Decision: Pfizer Inc. (PFE) v. Teva Pharmaceuticals USA Inc., 12-1576, U.S. Court of Appeals for the Federal Circuit (Washington)" (PDF). Diarsipkan (PDF) dari versi aslinya tanggal October 29, 2020. Diakses tanggal October 26, 2020.
"Pfizer's failed pregabalin patent appeal means NHS could reclaim £502m". Pulse. November 14, 2018. Diarsipkan dari asli tanggal November 15, 2018. Diakses tanggal May 17, 2024.
"Pregabalin international brands". Drugs.com. Diarsipkan dari versi aslinya tanggal August 28, 2019. Diakses tanggal October 27, 2017.

wfsbp.org

Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ (June 2012). "Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care" (PDF). International Journal of Psychiatry in Clinical Practice. 16 (2): 77–84. doi:10.3109/13651501.2012.667114. PMID 22540422. S2CID 16253034. Diarsipkan (PDF) dari versi aslinya tanggal April 3, 2018. Diakses tanggal October 16, 2020.

who.int

Expert Committee on Drug Dependence Forty-first Meeting (November 2018). Critical Review Report: Pregabalin (PDF) (Report). Geneva: World Health Organization. Diarsipkan dari asli (PDF) tanggal October 26, 2020.